addiction Archives -

According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis B, with most

How the WHO hepatitis strategy measures up in the field

https://pharmaphorum.com/partner-content/how-the-who-hepatitis-strategy-measures-up-in-the-field/

News/ News/ R&D

VC fund dedicated to psychedelic meds launches in UK

Phil Taylor addiction, anxiety, depression, financing, ketamine, mushrooms, Neo Kuma Ventures, psychedelics, UK, venture capital 0 Comment

In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms –

VC fund dedicated to psychedelic meds launches in UK

https://pharmaphorum.com/news/vc-fund-dedicated-to-psychedelic-meds-launches-in-uk/

News/ News/ Sales and Marketing

Purdue to pay $8.3bn after admitting criminal charges in opioid case

Phil Taylor addiction, litigation, opioid, opioid crisis, Purdue Pharma, US 0 Comment

After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in

Purdue to pay $8.3bn after admitting criminal charges in opioid case

https://pharmaphorum.com/news/purdue-to-pay-8-3bn-after-admitting-criminal-charges-in-opioid-case/

News/ News/ News/ Patients/ Sales and Marketing

After final $600M opioid settlement, Indivior looks to the future

Phil Taylor addiction, Indivior, litigation, opioid, opioid crisis, US 0 Comment

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in

After final $600M opioid settlement, Indivior looks to the future

https://pharmaphorum.com/news/after-final-600m-opioid-settlement-indivior-looks-to-the-future/

Digital/ News/ News/ Top stories

Orexo eyes launch of digital therapy for heavy drinkers this year

Phil Taylor addiction, alcohol use disorder, digital, Orexo, Vorvida 0 Comment

Orexo has submitted its Vorvida digital therapy for the treatment of heavy drinking for approval by the FDA,

Orexo eyes launch of digital therapy for heavy drinkers this year

https://pharmaphorum.com/news/orexo-eyes-launch-of-digital-therapy-for-heavy-drinkers-this-year/

Digital/ News/ News/ Top stories

Addiction firm Orexo licenses app for alcohol use disorder

Phil Taylor addiction, alcohol use disorder, digital, Orexo 0 Comment

Swedish drugmaker Orexo, best known for its opioid addiction therapies, has licensed rights to a digital therapy that

Addiction firm Orexo licenses app for alcohol use disorder

https://pharmaphorum.com/news/addiction-firm-orexo-licenses-app-for-alcohol-use-disorder/

Several Prescription Pill Bottles in a Pile

News/ News/ Patients

England is risking its own opioid epidemic, says PHE

Phil Taylor addiction, England, NHS England, opioid crisis, opioid epidemic 0 Comment

Hundreds of thousands of people in England are at risk of dependency on prescription medicines like opioid painkillers,

England is risking its own opioid epidemic, says PHE

https://pharmaphorum.com/news/england-is-risking-its-own-opioid-epidemic-says-phe/

News/ Top stories

FDA to reconsider Braeburn’s opioid addiction drug after court ruling

Richard Staines addiction, Braeburn, Indivior, opioids 0 Comment

A US district court has ruled that the FDA must reconsider its decision to reject a long-lasting opioid

FDA to reconsider Braeburn’s opioid addiction drug after court ruling

https://pharmaphorum.com/news/fda-to-reconsider-braeburns-opioid-addiction-drug-after-court-ruling/

News/ News/ R&D

Beckley Canopy Therapeutics raises £7.4m for cannabis R&D

George Underwood addiction, cannabis, opioid, pain 0 Comment

Oxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the

Beckley Canopy Therapeutics raises £7.4m for cannabis R&D

https://pharmaphorum.com/news/beckley-canopy-therapeutics-raises-7-4m-for-cannabis-rd/

Trending

addiction

Login